ACM
YTEN

AIGH Capital Management’s Yield10 Bioscience, Inc. Common Stock YTEN Stock Holding History

AIGH Capital Management’s Portfolio YTEN Stock Details YTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-14,320
Closed -$1.82M – 56
2022
Q1 		$1.82M Buy
14,320
+70
+0.5% +$7.23K 0.45% 29
2021
Q4 		$1.68M Hold
14,250
– – 0.51% 38
2021
Q3 		$2.05M Hold
14,250
– – 0.43% 44
2021
Q2 		$2.92M Sell
14,250
-1,583
-10% -$352K 0.53% 35
2021
Q1 		$4.76M Buy
+15,833
New +$5.36M 1% 29

Other funds holding YTEN

CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
CWP
Concord Wealth Partners Abingdon, Virginia $770M AUM 18.25% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

AIGH Capital Management's YTEN Position: Q2 2022 in Review

AIGH Capital Management sold out of Yield10 Bioscience, Inc. Common Stock (YTEN) in Q2 2022, closing a stake of 14,320 shares — an estimated $1.82M sold.

AIGH Capital Management first reported a position in YTEN in Q1 2021 and held it in 5 quarters. The position peaked at $4.76M in Q1 2021. 12 funds tracked by Wall St. Rank hold YTEN as of Q2 2022.

  • AIGH Capital Management reported no remaining Yield10 Bioscience, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • AIGH Capital Management sold 14,320 Yield10 Bioscience, Inc. Common Stock shares in Q2 2022, an estimated $1.82M.
  • AIGH Capital Management first reported a position in Yield10 Bioscience, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • AIGH Capital Management's Yield10 Bioscience, Inc. Common Stock position peaked at $4.76M in Q1 2021.
  • 12 funds tracked by Wall St. Rank held Yield10 Bioscience, Inc. Common Stock as of Q2 2022.

Based on AIGH Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.